{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:38:39Z","timestamp":1784039919445,"version":"3.55.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/rlu.0000000000000902","type":"journal-article","created":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T11:51:24Z","timestamp":1438948284000},"page":"e7-e13","source":"Crossref","is-referenced-by-count":37,"title":["Role of FDG-PET\/CT in Extramedullary Multiple Myeloma"],"prefix":"10.1097","volume":"41","author":[{"given":"Sree Harsha","family":"Tirumani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Sakellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Jacene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul B.","family":"Shinagare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil C.","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil H.","family":"Ramaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick D.","family":"Van den Abbeele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-29-20210204","first-page":"2014","article-title":"2015. Available at: . 2014.","year":"27","journal-title":"Accessed August"},{"key":"R2-29-20210204","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014.","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"R3-29-20210204","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/annonc\/mdp329","article-title":"Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients.","volume":"21","author":"Varettoni","year":"2010","journal-title":"Ann Oncol"},{"key":"R4-29-20210204","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1200\/JCO.2011.34.9290","article-title":"Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.","volume":"29","author":"Blade","year":"2011","journal-title":"J Clin Oncol"},{"key":"R5-29-20210204","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3324\/haematol.2012.078519","article-title":"Extramedullary involvement in multiple myeloma.","volume":"97","author":"Blade","year":"2012","journal-title":"Haematologica"},{"key":"R6-29-20210204","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3324\/haematol.2012.065698","article-title":"Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents.","volume":"97","author":"Usmani","year":"2012","journal-title":"Haematologica"},{"key":"R7-29-20210204","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3109\/10428190109099330","article-title":"Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma.","volume":"42","author":"Avigdor","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"R8-29-20210204","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.0902-4441.2005.t01-1-EJH2462.x","article-title":"Bortezomib: an effective agent in extramedullary disease in multiple myeloma.","volume":"76","author":"Laura","year":"2006","journal-title":"Eur J Haematol"},{"key":"R9-29-20210204","first-page":"832","article-title":"Extramedullary multiple myeloma escapes the effect of thalidomide.","volume":"89","author":"Rosinol","year":"2004","journal-title":"Haematologica"},{"key":"R10-29-20210204","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2214\/AJR.13.10856","article-title":"MRI features of extramedullary myeloma.","volume":"202","author":"Tirumani","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"R11-29-20210204","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/leu.2009.89","article-title":"International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma.","volume":"23","author":"Dimopoulos","year":"2009","journal-title":"Leukemia"},{"key":"R12-29-20210204","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/RLU.0b013e31825b2071","article-title":"FDG PET or PETCT for detecting intramedullary and extramedullary lesions in multiple myeloma: a systematic review and meta-analysis.","volume":"37","author":"Lu","year":"2012","journal-title":"Clin Nucl Med"},{"key":"R13-29-20210204","first-page":"609","article-title":"Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.","volume":"87","author":"Alegre","year":"2002","journal-title":"Haematologica"},{"key":"R14-29-20210204","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00256-006-0127-z","article-title":"3rd, Mulligan ME, Smith SE, et al. Comparison of imaging with FDG PETCT with other imaging modalities in myeloma.","volume":"35","author":"Breyer","year":"2006","journal-title":"Skeletal Radiol"},{"key":"R15-29-20210204","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2967\/jnumed.107.045641","article-title":"18F-FDG PETCT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.","volume":"49","author":"Fonti","year":"2008","journal-title":"J Nucl Med"},{"key":"R16-29-20210204","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3324\/haematol.12654","article-title":"FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma.","volume":"93","author":"Salaun","year":"2008","journal-title":"Haematologica"},{"key":"R17-29-20210204","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2214\/AJR.08.1633","article-title":"Whole-body MRI versus PET in assessment of multiple myeloma disease activity.","volume":"192","author":"Shortt","year":"2009","journal-title":"AJR Am J Roentgenol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000000902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:12:43Z","timestamp":1620972763000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201601000-00029"}},"subtitle":["Correlation of FDG-PET\/CT Findings With Clinical Outcome"],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000000902","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}